Preliminary evidence supporting a new enzymatic debridement product for use in chronic wounds

A new recombinant proteolytic enzyme, isolated from maggot saliva, with fibrinolytic action has been investigated through a series of non‐clinical toxicology and in‐vitro/in‐vivo pharmacology studies to explore its potential safety and efficacy as an enzymatic debridement agent for use in chronic wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fairlamb, David M., Kelety, Bela, Bachert, Anke, Scholtissek, Anika, Jones, Richard D., Davis, Stephen C., Kirsner, Robert S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333010/
https://www.ncbi.nlm.nih.gov/pubmed/36625224
http://dx.doi.org/10.1111/iwj.14079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333010/
https://www.ncbi.nlm.nih.gov/pubmed/36625224
http://dx.doi.org/10.1111/iwj.14079

Ejemplares similares